217 related articles for article (PubMed ID: 9202051)
1. Kallistatin is a potent new vasodilator.
Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein rK10-induced kinin-independent, direct activation of NO-formation and relaxation of rat isolated aortic rings.
Wassdal I; Hull R; Gerskowitch VP; Berg T
Br J Pharmacol; 1995 May; 115(2):356-60. PubMed ID: 7545521
[TBL] [Abstract][Full Text] [Related]
3. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling.
Chao J; Miao RQ; Chen V; Chen LM; Chao L
Biol Chem; 2001 Jan; 382(1):15-21. PubMed ID: 11258665
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
8. [Renal vascular responses of bradykinin in the isolated rat kidney].
Bagate K; Develioglu L; Michel B; Grima M; Imbs JL; Barthelmebs M
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1131-4. PubMed ID: 9404422
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats.
Chen LM; Chao L; Chao J
Hum Gene Ther; 1997 Feb; 8(3):341-7. PubMed ID: 9048201
[TBL] [Abstract][Full Text] [Related]
10. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
12. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
13. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
[TBL] [Abstract][Full Text] [Related]
14. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
15. Kallistatin in blood pressure regulation transgenic and somatic gene delivery studies.
Chao J; Chao L
Trends Cardiovasc Med; 1997 Nov; 7(8):307-11. PubMed ID: 21235901
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxation induced by the essential oil of Croton nepetaefolius and its constituents in rat aorta are partially mediated by the endothelium.
Magalhães PJ; Lahlou S; Jucá DM; Coelho-de-Souza LN; da Frota PT; da Costa AM; Leal-Cardoso JH
Fundam Clin Pharmacol; 2008 Apr; 22(2):169-77. PubMed ID: 18353112
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
Lopes-Martins RA; Antunes E; Oliva ML; Sampaio CA; Burton J; de Nucci G
Br J Pharmacol; 1994 Sep; 113(1):81-6. PubMed ID: 7529116
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide in the vasorelaxant and hypotensive effects of extracts and purified tannins from Geum japonicum.
Xie YW; Xu HX; Dong H; Fiscus RR; But PP
J Ethnopharmacol; 2007 Jan; 109(1):128-33. PubMed ID: 16939706
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta.
Andriambeloson E; Kleschyov AL; Muller B; Beretz A; Stoclet JC; Andriantsitohaina R
Br J Pharmacol; 1997 Mar; 120(6):1053-8. PubMed ID: 9134217
[TBL] [Abstract][Full Text] [Related]
20. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
